Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study
Janice P. Dutcher, Larry Leon, Judith Manola, David M. Friedland, Bruce Roth, George Wilding
Dive into the research topics of 'Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study'. Together they form a unique fingerprint.